SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-13-002087
Filing Date
2013-07-17
Accepted
2013-07-17 16:13:29
Documents
11
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1313391.htm 10-Q 845074
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 16864
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 16581
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5683
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 6041
  Complete submission text file 0001178913-13-002087.txt   5845825

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT ormp-20130531.xml EX-101.INS 424165
7 TAXONOMY EXTENSION SCHEMA ormp-20130531.xsd EX-101.SCH 34332
8 TAXONOMY EXTENSION CALCULATION LINKBASE ormp-20130531_cal.xml EX-101.CAL 43919
9 TAXONOMY EXTENSION DEFINITION LINKBASE ormp-20130531_def.xml EX-101.DEF 103838
10 TAXONOMY EXTENSION LABEL LINKBASE ormp-20130531_lab.xml EX-101.LAB 503396
11 TAXONOMY EXTENSION PRESENTATION LINKBASE ormp-20130531_pre.xml EX-101.PRE 197951
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 13972763
SIC: 2834 Pharmaceutical Preparations